CC · XBRL financial data

The Chemours Company financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (CC's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	1,487	1,361	1,350	1,538	1,501	1,359	1,368	1,615	1,495	1,329	1,381	1,591
Cost of goods and services sold	1,206	1,106	1,064	1,232	1,215	1,086	1,132	1,337	1,262	1,174	1,169	1,305
Gross profit	281	—	286	306	286	265	236	278	233	—	212	286
Research and development	28	26*	28	26	29	26*	27	28	26	27*	26	27
Selling, general and administrative	165	223*	142	139	135	169*	123	437	109	130*	147	469
Total operating expenses	317	263*	174	168	265	203*	183	483	139	161*	186	499
Interest expense	55	63*	63	66	69	67*	66	67	68	68*	69	68
Other income (expense)	102	(9)*	5	(1)	7	(2)*	5	2	16	3*	22	273
Income tax expense (benefit)	3	(55)*	15	12	(3)	12	4	119	(9)	(5)*	7	273
Net income (loss)	20	(18)	52	70	(27)	(8)	(4)	(381)	60	(47)	(29)	(274)
Earnings per share, basic USD per share	0.13	(0.12)	0.35	0.47	(0.18)	(0.05)	(0.03)	(2.54)	0.40	(0.31)	(0.19)	(1.81)
Earnings per share, diluted USD per share	0.13	(0.12)	0.34	0.46	(0.18)	(0.05)	(0.03)	(2.54)	0.40	(0.31)	(0.19)	(1.81)
Weighted average shares, basic millions of shares	149	149*	149	149	150	150*	150	150	150	150*	151	151
Weighted average shares, diluted millions of shares	150	145*	150	150	150	151*	150	150	151	150*	151	151

Balance sheet

CSV

Fiscal quarters (CC's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	852	1,203	746	604	596	713	464	502	613	670	563	671
Accounts receivable	753	509	692	788	825	619	704	813	817	562	645	773
Inventory	1,314	1,352	1,391	1,368	1,438	1,472	1,550	1,558	1,547	1,569	1,536	1,452
Total current assets	3,683	3,835	3,597	2,937	3,080	3,026	2,933	3,100	3,207	3,001	2,928	3,094
Property and equipment, net	3,119	3,216	3,209	3,157	3,173	3,183	3,131	3,121	3,090	3,078	3,040	3,028
Right-of-use asset	258	260	252	251	254	258	286	281	281	271	274	270
Goodwill	102	102	102	102	46	46	46	46	46	46	46	46
Total assets	7,948	8,251	7,978	7,249	7,463	7,515	7,394	7,488	7,570	7,382	7,267	7,150
Accounts payable	901	1,159	963	938	1,069	1,142	1,006	1,023	1,035	954	891	937
Accrued liabilities	1,039	1,058	1,019	382	447	393	401	608	589	506	462	683
Total current liabilities	2,195	2,486	2,231	1,557	1,777	1,803	1,673	1,850	1,880	1,686	1,609	1,861
Long-term debt	3,944	3,987	3,968	3,951	3,988	4,054	4,064	4,102	4,098	4,099	4,100	3,838
Lease liability, non-current	207	206	198	195	196	194	213	206	203	191	192	191
Total liabilities	7,191	7,512	7,224	6,524	6,804	6,910	6,814	7,249	7,270	7,131	7,051	7,198
Retained earnings	1,845	1,782	1,797	1,828	1,763	1,718	1,659	1,265	1,312	1,220	1,178	891
Total stockholders' equity	755	737	752	723	657	604	579	237	298	250	215	(49)
Total liabilities and equity	7,948	8,251	7,978	7,249	7,463	7,515	7,394	7,488	7,570	7,382	7,267	7,150
Common shares outstanding (cover page) millions of shares	148	149	149	149	149	149	150	150	150	150	150	150

Cash flows

CSV

Fiscal quarters (CC's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	20	(18)	52	70	(27)	(8)	(4)	(381)	60	(47)	(29)	(274)
Stock-based compensation	6*	5*	1	6*	5*	3*	5	7*	5*	4*	7	7*
Depreciation and amortization	76	74*	71	74	78	78*	88	91	80	81*	79	80
Net cash from operating activities	130*	484*	(290)	(620)*	139*	138*	(112)	93*	146*	137*	(44)	158*
Purchases of property and equipment	86*	135*	102	73*	76*	109*	84	43*	41*	45*	49	44*
Net cash from investing activities	58*	(130)*	(101)	(70)*	(75)*	(107)*	(86)	(42)*	(35)*	(43)*	(44)	239*
Share repurchases	18*	0*	—	—	—	—	—	—	—	—	—	—
Dividends paid	37*	37*	37	37*	38*	36*	37	13*	13*	15*	13	13*
Net cash from financing activities	325*	(7)*	(54)	(40)*	(27)*	85*	(57)	(27)*	(5)*	(37)*	(19)	(289)*
Net change in cash	502*	360*	(454)	(734)*	47*	97*	(249)	39*	112*	59*	(109)	108*

Compare with peers

SIC 2800 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2800 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Chemours	671	1,591	158*	150.5M	—	Q2 FY26 10-QJun 30, 2026
Huntsman	359	1,717	not reported	175.3M	—	Q3 FY26 10-QSep 30, 2026
Ingevity	97	314	(14)*	34.4M	7.1 quarters	Q2 FY26 10-QJun 30, 2026
Perimeter Solutions	83	214	(0.7)*	163.7M	126.6 quarters	Q2 FY26 10-QJun 30, 2026
Innospec	250	491	7.2*	24.6M	—	Q2 FY26 10-QJun 30, 2026
OLIN	215	1,748	110*	114.0M	—	Q3 FY26 10-QSep 30, 2026
Solstice Advanced Materials	750	1,148	262*	158.8M	—	Q2 FY26 10-QJun 30, 2026
Ecovyst	88	250	34*	109.5M	—	Q2 FY26 10-QJun 30, 2026
Balchem	66	291	70*	31.8M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.